Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, Gibbs PE. Maines MD, et al. Among authors: miralem t. J Biol Chem. 2007 Mar 16;282(11):8110-22. doi: 10.1074/jbc.M513427200. Epub 2007 Jan 16. J Biol Chem. 2007. PMID: 17227757 Free article.
Human biliverdin reductase (hBVR), a dual specificity kinase (Ser/Thr/Tyr) is, as protein kinase C (PKC) betaII, activated by insulin and free radicals (Miralem, T., Hu, Z., Torno, M. D., Lelli, K. M., and Maines, M. D. (2005) J. Biol. Chem. 280, 17084-17092; Lerner …
Human biliverdin reductase (hBVR), a dual specificity kinase (Ser/Thr/Tyr) is, as protein kinase C (PKC) betaII, activated by insulin and fr …
Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).
Gibbs PE, Miralem T, Lerner-Marmarosh N, Tudor C, Maines MD. Gibbs PE, et al. Among authors: miralem t. J Biol Chem. 2012 Jan 6;287(2):1066-79. doi: 10.1074/jbc.M111.279612. Epub 2011 Nov 7. J Biol Chem. 2012. PMID: 22065579 Free PMC article.
Biliverdin reductase: a target for cancer therapy?
Gibbs PE, Miralem T, Maines MD. Gibbs PE, et al. Among authors: miralem t. Front Pharmacol. 2015 Jun 3;6:119. doi: 10.3389/fphar.2015.00119. eCollection 2015. Front Pharmacol. 2015. PMID: 26089799 Free PMC article. Review.
24 results